Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
Ref. MDA/2004/047
Issued: 27 September 2004
| IMMEDIATE ACTION | |
| ACTION | ![]() |
| UPDATE | ![]() |
| INFORMATION REQUEST |
| Further Information | |||||||
|---|---|---|---|---|---|---|---|
| DEVICE: Trilucent (soya bean oil filled) breast implants. |
> |
||||||
| PROBLEM: Previously identified risk from Trilucent breast implants; actions following conclusion of research and update of HN2000(05). |
> |
||||||
| ACTION BY: Plastic, reconstructive and oncological surgeons. |
|||||||
| ACTION: See actions on page 2. |
> |
||||||
|
DISTRIBUTED to:
* via CE Bulletin |
> |
||||||
| CONTACTS: Details of the company with product liability (AEI Inc) and Trilucent Care Centre, MHRA contacts for technical and clinical aspects. |
> |
||||||
| FEEDBACK REQUIREMENTS: Inform the Trilucent Care Centre, AEI Inc and MHRA of any incidents associated with the use of Trilucent breast implants. |
> Further information supplied in the following pages.


